Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/Bu8JdM0D5vY/268805.php
Wednesday, 20 November 2013
How basic scientists help the pharmaceutical industry market drugs
In a new perspective, published today (19 November) in the open access journal PLOS Biology, Adriane Fugh-Berman MD charges that basic science, not just clinical trials, is plagued by financial conflicts of interest. Fugh-Berman identifies evidence showing that industry-funded studies on animals and cell cultures can be as biased as industry-funded clinical trials, and can distort data on medical treatments.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment